![Hans Lennernäs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Lennernäs
Fondateur chez Canthera AB
Postes actifs de Hans Lennernäs
Sociétés | Poste | Début | Fin |
---|---|---|---|
Recipharm Pharmaceutical Development AB | Directeur/Membre du Conseil | - | - |
Hans Lennernäs Biomedical AB
![]() Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Hans Lennernäs Biomedical AB is a private company based in Uppsala, Sweden. The Swedish company provides medical research, development, and teaching services. Additionally, they own and manage real estate. | Directeur/Membre du Conseil | - | - |
Canthera AB
![]() Canthera AB Pharmaceuticals: MajorHealth Technology Canthera AB is a Swedish company that develops, manufactures, and wholesales pharmaceuticals and medical equipment. The private company is based in Uddevalla, Sweden. The company was founded by Hans Lennernäs. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - |
Historique de carrière de Hans Lennernäs
Anciens postes connus de Hans Lennernäs
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Uppsala | Corporate Officer/Principal | - | - |
DuoCort Pharma AB
![]() DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Fondateur | - | - |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
NANOLOGICA AB | Directeur/Membre du Conseil | 01/01/2014 | - |
Independent Dir/Board Member | 01/01/2014 | - | |
LIDDS AB | Directeur/Membre du Conseil | 23/02/2010 | - |
Fondateur | 01/01/2003 | - | |
Corporate Officer/Principal | 30/06/2011 | - |
Formation de Hans Lennernäs
University of Uppsala | Doctorate Degree |
Statistiques
Internationale
Suède | 9 |
Opérationnelle
Director/Board Member | 6 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
LIDDS AB | Health Technology |
NANOLOGICA AB | Health Technology |
Entreprise privées | 5 |
---|---|
Recipharm Pharmaceutical Development AB | Health Technology |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Health Technology |
Hans Lennernäs Biomedical AB
![]() Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Hans Lennernäs Biomedical AB is a private company based in Uppsala, Sweden. The Swedish company provides medical research, development, and teaching services. Additionally, they own and manage real estate. | Commercial Services |
DuoCort Pharma AB
![]() DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
Canthera AB
![]() Canthera AB Pharmaceuticals: MajorHealth Technology Canthera AB is a Swedish company that develops, manufactures, and wholesales pharmaceuticals and medical equipment. The private company is based in Uddevalla, Sweden. The company was founded by Hans Lennernäs. | Health Technology |
- Bourse
- Insiders
- Hans Lennernäs
- Expérience